Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta
- 30 September 1992
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 121 (3) , 477-480
- https://doi.org/10.1016/s0022-3476(05)81809-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hypercalciuria in children severely affected with osteogenesis imperfectaThe Journal of Pediatrics, 1991
- Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosisThe Journal of Pediatrics, 1991
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- EFFECTS OF INTRANASAL CALCITONIN ADMINISTRATION ON PITUITARY GH RESPONSE TO hGHRH (1–29)NH2IN NORMAL ADULT SUBJECTSClinical Endocrinology, 1989
- Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosisClinical Rheumatology, 1989
- Intranasal absorption of salmon calcitoninCalcified Tissue International, 1987
- Malignant Hypercalcemia—a Hospital SurveyActa Medica Scandinavica, 1986
- Improved method for the evaluation of 3-hydroxyproline and 4-hydroxyproline in the urineJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Therapy of osteogenesis imperfecta with synthetic salmon calcitoninThe Journal of Pediatrics, 1979
- Genetic heterogeneity in osteogenesis imperfecta.Journal of Medical Genetics, 1979